WANG Jingjing, WANG Huiyan, ZHANG Lingling, XIAO Jing, HU Weiguo, ZHANG Caixia, ZHOU Jie. Technical analysis of low molecule weight heparins patents and R&D suggestions[J]. Journal of China Pharmaceutical University, 2015, 46(4): 504-508. DOI: 10.11665/j.issn.1000-5048.20150420
Citation:
WANG Jingjing, WANG Huiyan, ZHANG Lingling, XIAO Jing, HU Weiguo, ZHANG Caixia, ZHOU Jie. Technical analysis of low molecule weight heparins patents and R&D suggestions[J]. Journal of China Pharmaceutical University, 2015, 46(4): 504-508. DOI: 10.11665/j.issn.1000-5048.20150420
WANG Jingjing, WANG Huiyan, ZHANG Lingling, XIAO Jing, HU Weiguo, ZHANG Caixia, ZHOU Jie. Technical analysis of low molecule weight heparins patents and R&D suggestions[J]. Journal of China Pharmaceutical University, 2015, 46(4): 504-508. DOI: 10.11665/j.issn.1000-5048.20150420
Citation:
WANG Jingjing, WANG Huiyan, ZHANG Lingling, XIAO Jing, HU Weiguo, ZHANG Caixia, ZHOU Jie. Technical analysis of low molecule weight heparins patents and R&D suggestions[J]. Journal of China Pharmaceutical University, 2015, 46(4): 504-508. DOI: 10.11665/j.issn.1000-5048.20150420
An analysis of low molecule weight heparins(LMWH)patents throughout China and aroud the world is made. The suggestion, in terms of patent technical solution, is given to the R&D of LMWH, especially the enoxaparin, dalteprin and nadroparin.
Lei ND.New drugs to sweeten,the pattern of the anticoagulant markets around the world changes highlighted(新型药物搅局,全球抗凝血药市场格局变化凸显)[J].China Prescr Drug(中国处方药),2013,11(7): 5-7.